CVS Health Corporation has declared a quarterly dividend of $1.20 per share, reflecting sustained financial strength. The move follows positive outlooks from Cantor Fitzgerald and Bernstein, reinforcing investor confidence in the healthcare provider’s long-term strategy.
- CVS Health approved a $1.20 quarterly dividend per share, payable on March 15, 2026.
- This is the 19th consecutive quarter of dividend increases.
- Adjusted EPS rose 7% YoY to $2.45 in Q4 2025.
- Revenue grew 5.3% YoY to $35.2 billion in Q4 2025.
- Cantor Fitzgerald and Bernstein maintain 'outperform' ratings with upward price target revisions.
- Forward dividend yield stands at 3.7%, supporting appeal for income investors.
CVS Health Corporation's board of directors has authorized a quarterly cash dividend of $1.20 per share, payable on March 15, 2026, to shareholders of record as of February 15, 2026. This marks the 19th consecutive quarter of dividend increases, underscoring the company’s commitment to returning value to investors. The dividend is consistent with CVS Health’s ongoing capital allocation framework focused on shareholder returns and strategic reinvestment. The announcement coincides with revised upward price targets from investment firms Cantor Fitzgerald and Bernstein, both of which have reiterated 'outperform' ratings on CVS Health stock. While specific target prices were not disclosed, the analysts cited improvements in pharmacy margins, strong performance in the pharmacy benefit management (PBM) segment, and continued growth in its health care services division as key drivers of near-term earnings momentum. Financial metrics support the optimism: CVS Health reported adjusted EPS of $2.45 for the fourth quarter of 2025, up 7% year-over-year, driven by volume growth in retail pharmacy and expansion within its MinuteClinic network. Revenue totaled $35.2 billion, a 5.3% increase compared to the same period in 2024. These results reflect solid execution despite macroeconomic headwinds affecting consumer spending. The dividend hike and analyst sentiment are expected to bolster investor interest in CVS Health shares, particularly among income-focused portfolios. The stock is currently trading at approximately $128 per share, with a forward dividend yield of 3.7%. Market participants are closely watching the company’s upcoming earnings call for further guidance on 2026 revenue projections and PBM pricing trends.